Hyperbaric oxygen therapy (HBOT) for Tinnitus: What Does the Evidence Show?

Complementary & Alternative

Scope of this assessment. This page assesses treatments for tinnitus itself. Sudden hearing loss, with or without tinnitus, is a different and urgent situation: get a medical evaluation right away if your hearing suddenly drops or seems muffled (all at once or over a few days), even if it began several days ago. Some treatments are time-limited, but that is a reason to be seen now, not permission to wait. For sudden sensorineural hearing loss, the 2019 U.S. guideline (AAO-HNSF) lists hyperbaric oxygen combined with steroids as an option within 2 weeks of onset and as salvage therapy within 1 month of onset. That advice concerns hearing recovery; this page's negative conclusion applies to chronic tinnitus. In the UK, NICE says people with tinnitus and hearing loss that developed suddenly (over 3 days or less) in the past 30 days should be seen within 24 hours. This is not medical advice. Sources: AAO-HNSF sudden hearing loss guideline (2019) · NICE NG155 referral recommendations

Current evidence

Oxygen chambers are sold for tinnitus at hundreds of dollars a session; Cochrane says routine use 'cannot be justified'.

Evidence strength: Limited (2/5) · Tier 5 — weak or unsupported · Evidence independence: Primarily independent.

Breathing 100% oxygen at above-atmospheric pressure in a chamber; marketed by private hyperbaric clinics for tinnitus and sudden hearing loss.

Did tinnitus loudness or distress improve?

🔉 Did tinnitus loudness improve?
None shown.

Cochrane (7 RCTs, N=392): significance of any tinnitus improvement 'could not be assessed'; no benefit for tinnitus present over 6 months.

🧠 Did tinnitus distress improve?
None shown.

Same review: small, methodologically poor studies; routine use not justified.

Loudness means the tinnitus percept itself became quieter (psychoacoustic matching or loudness ratings). Distress means questionnaire scores such as THI/TFI, sleep, anxiety or quality of life improved — the sound may be unchanged. A THI/TFI improvement is never evidence the tinnitus got quieter.

How strong is the evidence?

Cochrane-reviewed and unsupported for chronic tinnitus: Tier 5.

What the studies found 1 tracked

Hyperbaric oxygen for idiopathic sudden hearing loss and tinnitus (Cochrane Review)

Bennett MH, et al. · Cochrane Database of Systematic Reviews · 2012 · N=392 (7 RCTs) · Systematic review

Studies small and methodologically poor; 'the significance of any improvement in tinnitus could not be assessed'; no benefit for chronic (>6-month) tinnitus; routine use cannot be justified.

PubMed 23076907 · DOI 10.1002/14651858.CD004739.pub4

What are the limitations?

Has the result been independently replicated?

None yet.

What should patients know about safety?

Safety evidence: Moderate. Barotrauma risk, temporary myopia, oxygen toxicity at extremes; plus significant cost.

Is it available?

Regulatory status: FDA-regulated chambers; tinnitus is NOT an approved indication.

Availability: Private clinics, $150–400/session · Europe: Same · Cost (approx.): $150–400/session, multi-session courses

Related treatments 4

Evidence last reviewed: 2026-09-04 · Evidence included through: 2026-09-04 · Confidence: high. Open the interactive evidence profile · How we rate evidence.

This page summarizes published research for education. It is not medical advice; it cannot say what will work for any individual. Discuss treatment decisions with a qualified clinician.